Jose Manuel Otero

Insider Reports History

Location
New York, NY
Signature
/s/ Carole Rosenberg, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jose Manuel Otero:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Operating Officer Common Stock 125,460 $802,592 $6.40 18 Feb 2026 Direct
Lexeo Therapeutics, Inc. Chief Operating Officer Stock Option (right to buy) 260,000 04 Feb 2026 Direct

Insider Reports Filed by Jose Manuel Otero

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 18 Feb 2026 1 -$19,294 4 Chief Operating Officer 20 Feb 2026, 17:05
LXEO Lexeo Therapeutics, Inc. 04 Feb 2026 2 $0 4 Chief Operating Officer 06 Feb 2026, 17:00
LXEO Lexeo Therapeutics, Inc. 18 Nov 2025 1 -$6,684 4/A Chief Operating Officer 20 Feb 2026, 17:05
LXEO Lexeo Therapeutics, Inc. 15 Oct 2025 3 -$18,913 4 Chief Technical Officer 17 Oct 2025, 19:28
LXEO Lexeo Therapeutics, Inc. 18 Aug 2025 1 -$13,294 4 Chief Technical Officer 20 Aug 2025, 17:05
LXEO Lexeo Therapeutics, Inc. 14 Mar 2025 1 +$14,929 4 Chief Technical Officer 09 Apr 2025, 17:48
LXEO Lexeo Therapeutics, Inc. 07 Jan 2025 2 $0 4 Chief Technical Officer 10 Jan 2025, 16:55
LXEO Lexeo Therapeutics, Inc. 12 Jun 2024 2 $0 4 Chief Technical Officer 14 Jun 2024, 09:04
LXEO Lexeo Therapeutics, Inc. 20 May 2024 0 $0 3 Chief Technical Officer 22 May 2024, 17:03